Neuland Laboratories Limited. — Earnings Release 2021

Aug 4, 2021

Neu land Laboratories Limited 11th Floor (5th Office Level), Phoenix IVY Building, Plot No.573A·ll1, Road No.82, Jubilee Hills, Hyderabad - 500033, Telangana, India.

Tel: 040 67611600 / 67611700 Email: neuland@neulandlabs.com www.neulandlabs.com

August 4, 2021

To BSE Limited Phiroze Jeejeebhoy Towers, 25th Floor, Dalal Street, Mumbai - 400 001

To The National Stock Exchange of India Ltd Exchange Plaza, Bandra Kurla Complex, Bandra (E) Mumbai - 400 001

Scrip Code: 524558

Scrip Code: NEULANDLAB; Series: EQ

Dear Sirs',,

Sub: Compliance with Regulation 47(1 )(b) of the SEBI Listing Regulations, 2015

Please find attached herewith copies of the newspaper publication of Unaudited Financial Results for the quarter ended June 30, 2021, published in Financial Express and Andhra Prabha on August 4, 2021 for your reference.

This is for your information and records.

Thanking you,

Yours faithfully,

Encl : As above

FINANCIAL EXPRESS

NEULAND LABORATORIES LIMITED

(CIN: L85195TG1984PLC004393)

Regd. Office: 11th Floor (5th Office Level), Phoenix IVY Building, Plot No. 573A-III, Road No 82, Jubilee Hills, Hyderabad - 500033

EXTRACT OF CONSOLIDATED UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30 JUNE 2021 (Amount in lakhs of ₹, unless otherwise stated)

SI. No.	Particulars	Quarter Ended 30.06.2021	Quarter Ended 30.06.2020	Year Ended 31.03.2021
	Revenue from operations	20,088.67	20.542.38	93,691.31
2	Net profit for the period before tax	1,207.32	2,031.02	10.533.35
3	Net profit for the period after tax	873.45	1,516.30	8,063.07
4	Total comprehensive income for the period	871.92	1.521.16	7.906.60
5	Paid-up Equity Share Capital (Face value - z10 each)	1,290.05	1,290.05	1,290.05
6 $\overline{7}$	Other equity (excluding revaluation reserves) as shown in the audited balance sheet			77,271.83 As at 31.03.2021
	Earnings Per Share (of ₹10 each) (In absolute ₹ terms)
	(a) Basic	6.81	11.82	62.85
	(b) Diluted	6.81	11.82	62.85

Note 1: The financial results for the quarter ended 30 JUNE 2021 have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on 03 August 2021.

Particulars	Ouarter Ended 30.06.2021	Ouarter Ended 30.06.2020	Year Ended 31.03.2021
Revenue from operations	20.088.67	20.542.38	93.691.31
Net profit for the period before tax	1.198.61	2.020.40	10,496.21
Net profit for the period after tax	864.76	1.505.68	8,029.49

Note 3: The above is an extract of the detailed format of Unaudited Financial Results filed with the Stock Exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The full format of the Unaudited Financial Results are available on the Stock Exchange websites, www.nseindia.com and www.bsein Company's website www.neulandlabs.com

By Order of the Board For Neuland Laboratories Limited Dr. D.R.Rao

Executive Chairman (DIN 00107737)

Place: Hyderabad Date: 03 August 2021

	ఆంధ్రవైభ్ హైదరాబాద్ బుధవారం 4 ఆగస్టు 2021

	NEULAND LABORATORIES LIMITED (CIN: L85195TG1984PLC004393) Regd. Office: 11th Floor (5th Office Level), Phoenix IVY Building, Plot No. 573A-III, Road No 82, Jubilee Hills, Hyderabad - 500033 EXTRACT OF CONSOLIDATED UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30 JUNE 2021			neuland
SI. No.	Particulars	Quarter Ended 30.06.2021	Quarter Ended 30.06.2020	(Amount in lakhs of ₹, unless otherwise stated) Year Ended 31.03.2021
1 2 3 $\overline{4}$ 5 6 $\overline{7}$	Revenue from operations Net profit for the period before tax Net profit for the period after tax Total comprehensive income for the period Paid-up Equity Share Capital (Face value - z10 each) Other equity (excluding revaluation reserves) as shown in the audited balance sheet Earnings Per Share (of ₹10 each) (In absolute ₹ terms) (a) Basic (b) Diluted	20,088.67 1,207.32 873.45 871.92 1,290.05 6.81 6.81	20,542.38 2,031.02 1,516.30 1,521.16 1,290.05 11.82 11.82	93,691.31 10,533.35 8,063.07 7,906.60 1,290.05 77,271.83 As at 31.03.2021 62.85 62.85
	Note 1: The financial results for the quarter ended 30 JUNE 2021 have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on 03 August 2021. Note 2: Key Standalone Financial Information:
	Particulars	Quarter Ended 30.06.2021	Quarter Ended 30.06.2020	Year Ended 31.03.2021
Revenue from operations Net profit for the period before tax Net profit for the period after tax		20,088.67 1,198.61 864.76	20,542.38 2.020.40 1,505.68	93,691.31 10,496.21 8,029.49
	Note 3: The above is an extract of the detailed format of Unaudited Financial Results filed with the Stock Exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The full format of the Unaudited Financial Results are available on the Stock Exchange websites, www.nseindia.com and www.bseindia.com and on the Company's website www.neulandlabs.com Place: Hyderabad Date: 03 August 2021			By Order of the Board For Neuland Laboratories Limited Dr. D.R.Rao Executive Chairman (DIN 00107737)